CAS RN: 570406-98-3

Avatrombopag

Product Availability

Choose a grade to view its available package options.

11 package records11 with current stock4 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250314 10mg / 50mg / 250mg / 1g Confirm by inquiry Shanghai 5-7 business days Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20251211 100mg In stock Shanghai, Shenzhen, Tianjin Inquiry
Batchno.20250715 1g In stock Shanghai, Tianjin Inquiry
Batchno.20260626 250mg In stock Shanghai, Tianjin Inquiry
Batchno.20250405 5g In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250111 10mg In stock Inquiry
Batchno.20250831 1g In stock Inquiry
Batchno.20250908 250mg In stock Inquiry
Batchno.20250901 50mg In stock Inquiry
Batchno.20250713 5mg In stock Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250530 1ml In stock Inquiry
  • Product code: starshine_CAS570406-98-3
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

570406-98-3 / 1-[3-chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl]-2-pyridinyl]piperidine-4-carboxylic acid

Standard CAS: 570406-98-3 Multi CAS: Yes

Basic Information

CAS
570406-98-3
Multi CAS
Yes
Molecular Formula
C29H34CL2N6O3S2
Molecular Weight
649.700000
Exact Mass
648.151087
InChI
InChI=1S/C29H34Cl2N6O3S2/c30-20-15-23(41-17-20)24-27(37-12-10-35(11-13-37)21-4-2-1-3-5-21)42-29(33-24)34-26(38)19-14-22(31)25(32-16-19)36-8-6-18(7-9-36)28(39)40/h14-18,21H,1-13H2,(H,39,40)(H,33,34,38)
InChIKey
OFZJKCQENFPZBH-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
42
Aromatic heavy atom count
16
Fraction Csp3
0.52
Rotatable bonds
7
H-bond acceptors
9
H-bond donors
2
Molar refractivity
170.87
TPSA
101.9

LogP / Solubility

WLOGP
6.58
MLOGP
5.85
XLogP3
4
Consensus LogP
5.48
Log S (ESOL)
-7.83
Class (ESOL)
Insoluble
Log S (Ali)
-9.64
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-10.19
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.01

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
5.5

Get In Touch

Contact Us